Immunofluorescence Analyzer Market

Immunofluorescence Analyzer Market 2018-2028: Biotech & Pharma Players Contribute a Major Revenue Share

Market Overview

The increasing prevalence of chronic diseases is necessitating demand for immunofluorescence analyzers

Immunofluorescence analysis is a process used to analyze the distribution of protein, glycan, and small biological as well as non-biological molecules, such as tissues and cells, using the antibodies associated with a fluorescent dye, which is also known as a fluorophore. This procedure enables the viewing of molecules using an imaging system or fluorescence microscope.

Immunofluorescence analysis is a biochemical test that is used to identify and analyze a specific substance in the blood or body fluid sample with the help of an antigen or antibody. Immunofluorescence analysis is a highly specific and sensitive method of study due to the usage of antibodies and purified antigens in the form of reagents. Immunofluorescence analyzers are commonly used for the measurement of drugs, hormones, tumor markers, cardiac injury markers, and specific proteins. Higher sensitivity, simplified reagents, and assay designs are some of the advantages associated with the usage of immunofluorescence analyzers.

Increasing R&D spending and frequent products innovations remain major contributors toward immunofluorescence analyzer market growth

The immunofluorescence analyzers market is gaining traction following the launch of innovative products and various technological advancements, such as compactness, portability, and real-time monitoring, in point-of-care analysis systems.

  • For example, AESKU group launched its new HELIOS automated immunofluorescence analyzer system accompanied by AESKUSLIDES ANA HEp-2-Gamma analysis. HELIOS is built upon the computerized system for immunofluorescence processing by recapturing the image with a fluorescence microscope using integrated software. In a single analysis, HELIOS can process and analyze various patient samples. In over 40 countries, more than 300 HELIOS immunofluorescence analyzer systems are being used.

The biotechnology and pharmaceutical companies account for a significant share of the global immunofluorescence analyzer market. Various factors, such as the increasing usage of immunofluorescence assays in the study of different diseases as well as drug discovery, as well as developments in the processes of critical companies, are contributing to the growth of immunofluorescence analyzer market.

The increasing frequency of chronic conditions and infectious diseases, which require prevention, early diagnosis, and treatment, is also among the key factors boosting the demand for immunofluorescence analyzers in the healthcare sector.

Immunofluorescence Analyzer Market: Regional Outlook

The North America region holds a significantly high share of the global immunofluorescence analyzer market. The government authorities of the region and private companies operating in the region, which are among the important stakeholders in the development of and innovations in technology, have supported research funding as well as helped in the commercialization of immunofluorescence analyzers in the North America region.

  • For instance, in 2017, Siemens Healthineers introduced the Atellica Solution, an immunofluorescence analyzer solution that is very flexible with a bi-directional magnetic sample carrier, which is a patented technology. It is utilized as a convenient stand-alone system that offers 300 customizable arrangements and is scalable up to 10 components.

Europe accounts for a considerable share in the global immunofluorescence analyzer market followed by Latin America where high healthcare spending and increased health awareness are among the factors driving the market.

Moreover, Asia Pacific is projected to witness significant growth in the demand for immunofluorescence analyzers during the forecast period due to the increasing adoption of new technologies as well as the presence of a large population that is susceptible to various chronic diseases. 

The MEA region is expected to exhibit constant growth in the global immunofluorescence analyzer market during the forecast period.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Immunofluorescence Analyzer Market Segments
  • Immunofluorescence Analyzer Market Dynamics
  • Immunofluorescence Analyzer Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges in Immunofluorescence Analyzer Market
  • Competition & Companies Involved in Immunofluorescence Analyzer Market
  • Technology
  • Immunofluorescence Analyzer Market Value Chain
  • Immunofluorescence Analyzer Market Drivers and Restraints

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
  • Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)

Global Immunofluorescence Analyzer Market: Segmentation

The global immunofluorescence analyzer market can be segmented on the basis of product, end use, application, and region.

Immunofluorescence Analyzer Market by Product Type:

  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Radioimmunoassay
  • Enzyme Linked Fluorescent Immunoassay

Immunofluorescence Analyzer Market by End Use:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic and Research Institutes
  • Others

Immunofluorescence Analyzer Market by Application:

  • Direct Tissue Evaluation
  • Carcinogenic Cells Diagnosis
  • Therapeutic Drug Monitoring
  • Autoimmune Disease Diagnosis
  • Others

On the basis of end use, FTIR gas analysers market segmented into:

  • Automotive
  • Chemical
  • Agriculture
  • Oil and Gas
  • Research and Development
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Testing Equipment

View Reports

Recommendations

Immunofluorescence Analyzer Market